[go: up one dir, main page]

GB0326780D0 - Biological materials and uses thereof - Google Patents

Biological materials and uses thereof

Info

Publication number
GB0326780D0
GB0326780D0 GBGB0326780.4A GB0326780A GB0326780D0 GB 0326780 D0 GB0326780 D0 GB 0326780D0 GB 0326780 A GB0326780 A GB 0326780A GB 0326780 D0 GB0326780 D0 GB 0326780D0
Authority
GB
United Kingdom
Prior art keywords
biological materials
biological
materials
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0326780.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ip2ipo Innovations Ltd
Original Assignee
Imperial College Innovations Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial College Innovations Ltd filed Critical Imperial College Innovations Ltd
Priority to GBGB0326780.4A priority Critical patent/GB0326780D0/en
Publication of GB0326780D0 publication Critical patent/GB0326780D0/en
Priority to CNA2004800406378A priority patent/CN1906491A/en
Priority to AU2004292013A priority patent/AU2004292013A1/en
Priority to EP04798515A priority patent/EP1718979A2/en
Priority to PCT/GB2004/004795 priority patent/WO2005050203A2/en
Priority to JP2006540577A priority patent/JP2007515162A/en
Priority to CA002546401A priority patent/CA2546401A1/en
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/71—Assays involving receptors, cell surface antigens or cell surface determinants for growth factors; for growth regulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biotechnology (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
GBGB0326780.4A 2003-11-18 2003-11-18 Biological materials and uses thereof Ceased GB0326780D0 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
GBGB0326780.4A GB0326780D0 (en) 2003-11-18 2003-11-18 Biological materials and uses thereof
CNA2004800406378A CN1906491A (en) 2003-11-18 2004-11-15 Methods of screening using CTGF and TRKA receptor for the identification of compounds for use in treatment of fibrosis
AU2004292013A AU2004292013A1 (en) 2003-11-18 2004-11-15 Methods for screening using CTGF and TRKA receptor for the identification of compounds for use in treatment of fibrosis
EP04798515A EP1718979A2 (en) 2003-11-18 2004-11-15 Methods of screening using ctgf and trka receptor for the identification of compounds for use in treatment of fibrosis
PCT/GB2004/004795 WO2005050203A2 (en) 2003-11-18 2004-11-15 The methods for screening using ctgf and trka receptor for the identification of compounds for use in treatment of fibrosis
JP2006540577A JP2007515162A (en) 2003-11-18 2004-11-15 Screening method using CTGF and TRKA receptors for the identification of compounds used in the treatment of fibrosis
CA002546401A CA2546401A1 (en) 2003-11-18 2004-11-15 The methods for screening using ctgf and trka receptor for the identification of compounds for use in treatment of fibrosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0326780.4A GB0326780D0 (en) 2003-11-18 2003-11-18 Biological materials and uses thereof

Publications (1)

Publication Number Publication Date
GB0326780D0 true GB0326780D0 (en) 2003-12-24

Family

ID=29763971

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0326780.4A Ceased GB0326780D0 (en) 2003-11-18 2003-11-18 Biological materials and uses thereof

Country Status (7)

Country Link
EP (1) EP1718979A2 (en)
JP (1) JP2007515162A (en)
CN (1) CN1906491A (en)
AU (1) AU2004292013A1 (en)
CA (1) CA2546401A1 (en)
GB (1) GB0326780D0 (en)
WO (1) WO2005050203A2 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0326778D0 (en) * 2003-11-18 2003-12-24 Imp College Innovations Ltd Biological materials and uses thereof
US20060275797A1 (en) * 2005-03-21 2006-12-07 Alcon Manufacturing, Ltd. Use of agents which inhibit connective tissue growth factor (CTGF) binding and signaling via the TrkA/p75NTR receptor complex for the prevention and treatment of CTGF-mediated ocular disorders
MX2011002143A (en) * 2008-08-25 2011-07-20 Excaliard Pharmaceuticals Inc Antisense oligonucleotides directed against connective tissue growth factor and uses thereof.
US8946172B2 (en) 2008-08-25 2015-02-03 Excaliard Pharmaceuticals, Inc. Method for reducing scarring during wound healing using antisense compounds directed to CTGF
EP2169059A1 (en) * 2008-09-25 2010-03-31 Academisch Medisch Centrum bij de Universiteit van Amsterdam Means and methods for counteracting, preventing and/or determining fibrosis or a risk of fibrosis
EP2221387A1 (en) * 2009-02-19 2010-08-25 Université de la Méditerranée Fibrosis susceptibility gene and uses thereof
HUE044178T4 (en) 2011-02-02 2019-10-28 Excaliard Pharmaceuticals Inc Antisense compounds targeting connective tissue growth factor (ctgf) for use in a method of treating keloids or hypertrophic scars
CN107217092A (en) 2011-08-05 2017-09-29 艾克斯-马赛大学 Fibre modification neurological susceptibility IL22RA2 genes and application thereof
KR101467109B1 (en) * 2013-07-10 2014-12-01 영남대학교 산학협력단 Composition for preventing or treating pulmonary fibrosis comprising BIX02189 compound
PT3102555T (en) 2014-02-05 2021-06-04 VM Oncology LLC Compositions of compounds and uses thereof
US20220204630A1 (en) * 2019-05-30 2022-06-30 Sunshine Lake Pharma Co., Ltd. Anti-trka antibodies and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6555322B1 (en) * 1999-08-27 2003-04-29 Fibrogen, Inc. α2-macroglobulin receptor as a receptor for CTGF

Also Published As

Publication number Publication date
CA2546401A1 (en) 2005-06-02
WO2005050203A2 (en) 2005-06-02
JP2007515162A (en) 2007-06-14
CN1906491A (en) 2007-01-31
EP1718979A2 (en) 2006-11-08
AU2004292013A1 (en) 2005-06-02
WO2005050203A3 (en) 2005-11-17

Similar Documents

Publication Publication Date Title
HK1084883A1 (en) 2-cyanopyrrolopyrimidines and pharmaceutical uses thereof
IL191868A0 (en) Biological materials and uses thereof
AU2003284875A8 (en) Biological scaffolding material
GB0326780D0 (en) Biological materials and uses thereof
AP2127A (en) Multi-carbide material manufacture and use
IL172510A0 (en) Antibodies and uses thereof
HK1094531A1 (en) P185neu-encoding dna and therapeutical uses thereof
GB0326778D0 (en) Biological materials and uses thereof
GB0519398D0 (en) Biological materials and uses thereof
GB2400659B (en) Assay methods and materials
GB0318546D0 (en) Quinoxalinones and their use
GB0300804D0 (en) Compounds and their use
GB0300805D0 (en) Compounds and their use
GB0301143D0 (en) Compounds and their use
GB0321746D0 (en) Biological materials and uses thereof
GB0318063D0 (en) Biological material and uses thereof
GB0309203D0 (en) Biological material and uses thereof
EP1602666A4 (en) Novel protein and its dna
GB0519397D0 (en) Biological materials and uses thereof
EP1531179A1 (en) New biological entities and the use thereof
GB0321300D0 (en) Protein structure and uses thereof
GB0211496D0 (en) Disposable materials and articles
GB0309319D0 (en) Compounds and their use
GB0328147D0 (en) Compounds and their use
GB0309320D0 (en) Compounds and their use

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)